These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26259799)

  • 1. Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections.
    Rigatto MH; Vieira FJ; Antochevis LC; Behle TF; Lopes NT; Zavascki AP
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6575-80. PubMed ID: 26259799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii.
    Rigatto MH; Ribeiro VB; Konzen D; Zavascki AP
    Infection; 2013 Apr; 41(2):321-8. PubMed ID: 23124906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
    J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
    Sobieszczyk ME; Furuya EY; Hay CM; Pancholi P; Della-Latta P; Hammer SM; Kubin CJ
    J Antimicrob Chemother; 2004 Aug; 54(2):566-9. PubMed ID: 15269195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
    Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
    Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.
    Holloway KP; Rouphael NG; Wells JB; King MD; Blumberg HM
    Ann Pharmacother; 2006 Nov; 40(11):1939-45. PubMed ID: 17018688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.
    Chung JH; Bhat A; Kim CJ; Yong D; Ryu CM
    Sci Rep; 2016 Jun; 6():28168. PubMed ID: 27306928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Urban C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2732-4. PubMed ID: 20368401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin use as a risk factor for colonization or infection with polymyxin-resistant Acinetobacter baumannii after liver transplantation.
    Freire MP; Van Der Heijden IM; do Prado GV; Cavalcante LS; Boszczowski I; Bonazzi PR; Rossi F; Guimarães T; D'Albuquerque LA; Costa SF; Abdala E
    Transpl Infect Dis; 2014 Jun; 16(3):369-78. PubMed ID: 24725123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
    Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL; Loh C; Low JG; Kurup A; Tam VH
    Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.